3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Polycystic Ovary Syndrome
8
Neoplasms
3
Melanoma
3
Infertility
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Obesity
2
Metabolic Diseases
2
Insulin Resistance
2
Glioblastoma
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
TP53 Y220C Mutation
1
Sarcoma, Ewing
1
Sarcoma
1
Prostate Cancer Recurrent
1
Progression-Free Survival
1
Preleukemia
1
Posterior Fossa Ependymal Tumor
1
Osteosarcoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms by Site
1
Medulloblastoma
1
Leukoplakia, Oral
1
Leukemia, Myeloid, Acute
1
Hyperandrogenism
1
Interventions
mazdutide
1
lithium sulfate
1
lime
1
fasudil
1
blueberry extract
1
Walking
1
Transcranial Magnetic Stimulation
1
Transcranial Direct Current Stimulation
1
Therapeutics
1
Tablets
1
Radiotherapy
1
Patient Reported Outcome Measures
1
Organization and Administration
1
Neuropsychological Tests
1
Modafinil
1
Methods
1
Metformin
1
Memantine
1
Low-Level Light Therapy
1
Lithium
1
Infliximab
1
Drug Therapy
1
Data Collection
1
Cognitive Behavioral Therapy
1
Chemoradiotherapy
1
Accidental Falls
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Cognitive Dysfunction
×
Metformin
×
Clear all
NCT05230758
2026-05-01
Met Med Can
The Hospital for Sick Children
Phase 3
Recruiting
140 enrolled